Summary of findings: Molecular‐targeted therapy plus chemotherapy vs chemotherapy alone
Overall survival · people with advanced gastric cancer
Summary of findings: Molecular‐targeted therapy plus chemotherapy showed no clear difference in overall survival compared with chemotherapy alone (low certainty).
1 finding from 1 review
- Molecular‐targeted first‐line therapy for advanced gastric cancer 2016 · Cochrane Headline outcomes onlyHR 0.92 [0.8, 1.05]10 studies · 3843 participantsLow